Inici › Malaltia cardiovascular › Texas › Houston
Assaigs clínics de Malaltia cardiovascular a Houston, TX
24 estudis de Malaltia cardiovascular busquen participants en centres de Houston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
ReclutantFase 2
- Cardiovascular Specialists of Willowbrook, Houston
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
ReclutantFase 3
- Victorium Clinical Research, Houston
- Houston Research Institute, Houston
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
ReclutantFase 4
- Vital Heart and Vein, Humble · a 17 mi
Product Surveillance Registry
ReclutantEstudi observacional
- Houston, Houston
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
ReclutantFase 3
- Clinical Trial Site, Houston
- Clinical Trial Site, Houston
- Clinical Trial Site, Houston
- i 7 més
Zenith® Fenestrated+ Clinical Study
Reclutant
- Memorial Hermann Texas Medical Center/UT Health, Houston
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Reclutant
- CHI Saint Luke's Health-Baylor Saint Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
- The University of Texas Health Science Center at Houston, Houston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Reclutant
- Houston Methodist Hospital, Houston
- Memorial Hermann-Texas Medical Center, Houston
- Texas Heart Institute at Baylor St. Luke's Medical Center, Houston
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
ReclutantFase 3
- Baylor College Of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
ReclutantFase 2
- Clinical Research Site, Houston
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
ReclutantFase 4Voluntaris sans benvinguts
- University of Texas at Houston, Houston
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
ReclutantEstudi observacional
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
ReclutantFase 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- i 4 més
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
ReclutantFase 3
- East Texas Cardiology PA, Houston
- Baylor College of Medicine, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- i 1 més
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
ReclutantFase 3
- Kelsey Seybold Research Foundation, Houston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Reclutant
- Baylor/Texas Heart, Houston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Reclutant
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- Houston Methodist, Houston
- UTHealth Memorial Hermann, Houston
Pivotal Study for the Cardiac Performance System (CPS)
ReclutantEstudi observacional
- Baylor College of Medicine, Houston
DeBakey Cardiovascular Magnetic Resonance Study
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Houston Methodist Hospital, Houston
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
ReclutantFase 3
- Vital Heart and Vein, Humble · a 17 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Reclutant
- Houston Healthcare Medical Center, Houston
Randomized Trial of SGLT2i in Heart Transplant Recipients
ReclutantFase 4
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
ReclutantFase 2
- UT Health Houston, Houston
PARTNER 3 Trial - Aortic Valve-in-Valve
Reclutant
- The University of Texas Health Science Center at Houston, Houston
Assaigs de Malaltia cardiovascular en altres ciutats
- Boston, MA37 estudis
- New York City, NY33 estudis
- Washington, DC29 estudis
- Dallas, TX23 estudis
- Atlanta, GA22 estudis
- Cleveland, OH22 estudis
- Chicago, IL21 estudis
- Philadelphia, PA21 estudis
- Pittsburgh, PA20 estudis
- St. Louis, MO20 estudis
- San Francisco, CA18 estudis
- Nashville, TN18 estudis
Altres estudis a Houston
- Càncer de pulmó de cèl·lules no petites145 estudis
- Càncer de mama126 estudis
- Càncer (tots els tipus)121 estudis
- Càncer metastàtic104 estudis
- Càncer colorrectal102 estudis
- Càncer d'ovari89 estudis
- Leucèmia mieloide aguda85 estudis
- Càncer de pulmó78 estudis
- Càncer de pròstata76 estudis
- Càncer d'endometri68 estudis
- Càncer de pàncrees61 estudis
- Melanoma59 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.